Continuous central venous oxygen saturation assisted intraoperative hemodynamic management during major abdominal surgery a randomized, controlled trial /

Background: Major abdominal surgery is associated with significant risk of morbidity and mortality in the perioperative period. Optimising intraoperative fluid administration may result in improved outcomes. Our aim was to compare the effects of central venous pressure (CVP), and central venous oxyg...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Mikor András
Trásy Domonkos
Németh Márton Ferenc
Osztroluczki Angelika
Kocsi Szilvia
Kovács Ildikó
Demeter Gábor
Molnár Zsolt
Dokumentumtípus: Cikk
Megjelent: Biomed Central Ltd. 2015
Sorozat:BMC ANESTHESIOLOGY 15 No. 1
doi:10.1186/s12871-015-0064-2

mtmt:3079622
Online Access:http://publicatio.bibl.u-szeged.hu/11618
LEADER 03318nab a2200289 i 4500
001 publ11618
005 20200211144012.0
008 170622s2015 hu o 0|| zxx d
022 |a 1471-2253 
024 7 |a 10.1186/s12871-015-0064-2  |2 doi 
024 7 |a 3079622  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Mikor András 
245 1 0 |a Continuous central venous oxygen saturation assisted intraoperative hemodynamic management during major abdominal surgery  |h [elektronikus dokumentum] :  |b a randomized, controlled trial /  |c  Mikor András 
260 |a Biomed Central Ltd.  |c 2015 
300 |a 82-[Terjedelem: 10. p.] 
490 0 |a BMC ANESTHESIOLOGY  |v 15 No. 1 
520 3 |a Background: Major abdominal surgery is associated with significant risk of morbidity and mortality in the perioperative period. Optimising intraoperative fluid administration may result in improved outcomes. Our aim was to compare the effects of central venous pressure (CVP), and central venous oxygen saturation (ScvO<inf>2</inf>)-assisted fluid therapy on postoperative complications in patients undergoing high risk surgery. Methods: Patients undergoing elective major abdominal surgery were randomised into control and ScvO<inf>2</inf> groups. The target level of mean arterial pressure (MAP) was≥60 mmHg in both groups. In cases of MAP<60 mmHg patients received either a fluid or vasopressor bolus according to the CVP<8 mmHg in the control group. In the ScvO<inf>2</inf> group, in addition to the MAP, an ScvO<inf>2</inf> of <75 % or a >3 % decrease indicated need for intervention, regardless of the actual MAP. Data are presented as mean±standard deviation or median (interquartile range). Results: We observed a lower number of patients with complications in the ScvO<inf>2</inf> group compared to the control group, however it did not reach statistical significance (ScvO<inf>2</inf> group: 10 vs. control group: 19; p=0.07). Patients in the ScvO<inf>2</inf> group (n=38) received more colloids compared to the control group (n=41) [279(161) vs. 107(250) ml/h; p<0.001]. Both groups received similar amounts of crystalloid (1126±471 vs. 1049±431 ml/h; p=0.46) and norepinephrine [37(107) vs. 18(73) mcg/h; p=0.84]. Despite similar blood loss in both groups, the ScvO<inf>2</inf> group received more blood transfusions (63 % vs. 37 %; p=0.018). More patients in the control group had a postoperative PaO<inf>2</inf>/FiO<inf>2</inf><200 mmHg (23 vs. 10, p<0.01). Twenty eight day survival was significantly higher in the ScvO<inf>2</inf> group (37/38 vs. 33/41 p=0.018). Conclusion: ScvO<inf>2</inf>-assisted intraoperative haemodynamic support provided some benefits, including significantly better postoperative oxygenation and 28 day survival rate, compared to CVP-assisted therapy without a significant effect on postoperative complications during major abdominal surgery. © 2015 Mikor et al.; licensee BioMed Central. 
700 0 1 |a Trásy Domonkos  |e aut 
700 0 1 |a Németh Márton Ferenc  |e aut 
700 0 1 |a Osztroluczki Angelika  |e aut 
700 0 1 |a Kocsi Szilvia  |e aut 
700 0 1 |a Kovács Ildikó  |e aut 
700 0 1 |a Demeter Gábor  |e aut 
700 0 1 |a Molnár Zsolt  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/11618/1/art3A10.11862Fs12871_015_0064_2_u.pdf  |z Dokumentum-elérés